N. A. Agafonov

Development and internal validation of a serum biomarker signature for non-small cell lung cancer: an exploratory case–control study

Blood-based biomarkers are increasingly explored for their ability to distinguish non-small cell lung cancer (NSCLC) from non-malignant conditions. Single markers, however, often show limited performance, which has led to growing interest in combining multiple biological features. Aim. To develop a multivariable di...